Tuesday 20 May 2025

The Pharma Letter Podcast — Episode 32 — ICON's AI strategy: faster, smarter trials

Pharmaceutical
8 May 2025

More on this story...

Pharmaceutical
Pharma M&A deal value surges by 101% QoQ in Q1 2025 despite US political turbulence
2 May 2025
Pharmaceutical
HHS and NIH launch vaccine platform for pandemic-prone viruses
3 May 2025
Pharmaceutical
PhRMA submits comments to White House on artificial intelligence
3 April 2025


More ones to watch >


Today's issue

HHS, CMS set Most-Favored-Nation pricing targets
Pharmaceutical
HHS, CMS set Most-Favored-Nation pricing targets
20 May 2025
Pharmaceutical
Grünenthal appoints Maren Thurow to lead global comms
20 May 2025
Pharmaceutical
Australia’s digital health sector growing as global funding surges
20 May 2025
Biotechnology
CEO among 25% of staff out the door at cash-strapped Prime
20 May 2025
Pharmaceutical
Apnimed touts Phase III success for first-ever sleep apnea pill
20 May 2025
Biotechnology
BioNTech expands partnership with UK govt, pledging £1 billion investment
20 May 2025
Biotechnology
New $35 million partnership to advance blood disorder therapies
20 May 2025

Company Spotlight

A clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need.




More Features in Pharmaceutical

HHS, CMS set Most-Favored-Nation pricing targets
20 May 2025
Grünenthal appoints Maren Thurow to lead global comms
20 May 2025
Australia’s digital health sector growing as global funding surges
20 May 2025
Apnimed touts Phase III success for first-ever sleep apnea pill
20 May 2025


Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze